UK markets closed

BIO-key International, Inc. (BKYI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.5600-0.0500 (-3.11%)
As of 10:53AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close1.6100
Open1.5700
Bid0.0000 x 0
Ask0.0000 x 0
Day's range1.5600 - 1.5700
52-week range1.4900 - 15.3000
Volume2,011
Avg. volume66,914
Market cap2.824M
Beta (5Y monthly)0.43
PE ratio (TTM)N/A
EPS (TTM)-19.6200
Earnings date13 May 2024 - 17 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est18.00
  • GlobeNewswire

    BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq

    HOLMDEL, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), announced today that on April 17, 2024, it received a letter (the “Notification Letter”) from The Nasdaq Stock Market, LLC (“Nasdaq”) informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely fi

  • GlobeNewswire

    Switzerland’s Canton of Ticino Implements BIO-key’s Multi-Factor Authentication Solution in its Information Systems Center

    TICINO, Switzerland and HOLMDEL, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc.® (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, today announced that Switzerland’s Canton of Ticino (Ticino) has partnered with Asecus AG to implement BIO-key’s AuthControl Sentry login solution. In a significant enhancement to its digi

  • Insider Monkey

    BIO-key International, Inc. (NASDAQ:BKYI) Q4 2023 Earnings Call Transcript

    BIO-key International, Inc. (NASDAQ:BKYI) Q4 2023 Earnings Call Transcript April 2, 2024 BIO-key International, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, everyone. Thank you for standing by, and welcome to BIO-key International’s Fourth Quarter 2023 Conference […]